Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Lioudmila Tchistiakova
A Novel GUCY2C-CD3 T Cell Engaging Bispecific Construct (PF-07062119) for the Treatment of Gastrointestinal Cancers
Clinical Cancer Research
Cancer Research
Oncology
Development of PF-06671008, a Highly Potent Anti-P-Cadherin/Anti-Cd3 Bispecific DART Molecule With Extended Half-Life for the Treatment of Cancer
Antibodies
Drug Discovery
Allergy
Immunology
Related publications
An Anti–glypican 3/Cd3 Bispecific T Cell–redirecting Antibody for Treatment of Solid Tumors
Science Translational Medicine
Medicine
A Novel Bispecific Single-Chain Antibody for ADAM17 and CD3 Induces T-Cell-Mediated Lysis of Prostate Cancer Cells
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
A Novel Carcinoembryonic Antigen T-Cell Bispecific Antibody (CEA TCB) for the Treatment of Solid Tumors
Clinical Cancer Research
Cancer Research
Oncology
PS2 - 172 Preclinical Validation of a Novel CD33/CD3 Bispecific T-Cell Engager (BiTE) Antibody to Target Patient-Derived Glioblastoma Cells
Canadian Journal of Neurological Sciences
Medicine
Neurology
SY13-1Vasohibin-2 Is a Novel Molecular Target for the Treatment of Gastrointestinal Cancers
Annals of Oncology
Medicine
Oncology
Hematology
Cd20-TCB (Rg6026), a Novel “2:1” Format T-Cell-Engaging Bispecific Antibody, Induces Complete Remissions in Relapsed/Refractory B-Cell Non-Hodgkin's Lymphoma
Hematological Oncology
Medicine
Cancer Research
Oncology
Hematology
Efficient Elimination of Chronic Lymphocytic Leukaemia B Cells by Autologous T Cells With a Bispecific Anti-Cd19/Anti-Cd3 Single-Chain Antibody Construct
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
A Novel Bispecific Antibody Against Human CD3 and Ephrin Receptor A10 for Breast Cancer Therapy
PLoS ONE
Multidisciplinary
